# Killer Immunoglobulin-Like Receptor Transcripts Expression for the Diagnosis of Epidermotropic Cutaneous T Cell Lymphoma

> **NCT00748319** · NA · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 495 (actual)

## Conditions studied

- Mycosis Fungicides
- Sezary Syndrome
- Dermatitis
- Dermatitis, Exfoliative

## Interventions

- **OTHER:** Detection of KIR receptor by RT PCR

## Key facts

- **NCT ID:** NCT00748319
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2011-11
- **Final completion:** 2011-12
- **Target enrollment:** 495 (ACTUAL)
- **Last updated:** 2012-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00748319

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00748319, "Killer Immunoglobulin-Like Receptor Transcripts Expression for the Diagnosis of Epidermotropic Cutaneous T Cell Lymphoma". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT00748319. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*